Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 32.08
-1.72 (-5.09%)
At close: Mar 2, 2026
Hansa Biopharma AB Revenue
In the year 2025, Hansa Biopharma AB had annual revenue of 222.27M SEK with 29.74% growth. Hansa Biopharma AB had revenue of 75.99M in the quarter ending December 31, 2025, with 134.99% growth.
Revenue
222.27M
Revenue Growth
+29.74%
P/S Ratio
14.69
Revenue / Employee
1.78M
Employees
125
Market Cap
3.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 222.27M | 50.95M | 29.74% |
| Dec 31, 2024 | 171.32M | 37.22M | 27.76% |
| Dec 31, 2023 | 134.09M | -20.43M | -13.22% |
| Dec 31, 2022 | 154.53M | 120.65M | 356.12% |
| Dec 31, 2021 | 33.88M | 27.78M | 455.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 434.40M |
| Cantargia AB | 316.70M |
| BioInvent International AB | 226.50M |
| Genovis AB (publ.) | 129.65M |
| Egetis Therapeutics AB | 62.40M |
| Medivir AB | 8.50M |
| Xspray Pharma AB | 6.43M |
| Vicore Pharma Holding AB | 3.82M |
Hansa Biopharma AB News
- 12 days ago - Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA - PRNewsWire
- 19 days ago - Hansa Biopharma AB (publ) (HNSBF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Hansa Biopharma AB (STU:24H) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... - GuruFocus
- 19 days ago - Q4 2025 Hansa Biopharma AB Earnings Call Transcript - GuruFocus
- 19 days ago - Hansa Biopharma AB (publ) 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 19 days ago - Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 5 weeks ago - Hansa Biopharma AB: Hansa Biopharma has won the 2025 SwedenBIO Award - Finanz Nachrichten
- 5 weeks ago - Hansa Biopharma has won the 2025 SwedenBIO Award - PRNewsWire